Suplatast tosilate ameliorates airway hyperreactivity and inflammation through inhibition of the GATA-3/IL-5 signaling pathway in asthmatic rats

Molecular Medicine Reports

Volumn 8, Issue 1, 2013, Pages 161-167

  Tan, Yupin ^a   Li, Yun ^a   Liu, Dan ^a   Zhong, Lili ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Asthma; GATA binding protein 3; Hyperreactivity; Inflammation; Interleukin 5; Suplatast tosilate

Indexed keywords

BUDESONIDE; INTERLEUKIN 5; OVALBUMIN; SUPLATAST TOSYLATE; TRANSCRIPTION FACTOR GATA 3;

AIRWAY RESISTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL INFILTRATION; CONTROLLED STUDY; EOSINOPHIL; EPITHELIUM HYPERPLASIA; GOBLET CELL; LUNG PARENCHYMA; NONHUMAN; PROTEIN EXPRESSION; RAT; SENSITIZATION; SIGNAL TRANSDUCTION;

AIRWAY RESISTANCE; ANIMALS; ARYLSULFONATES; ASTHMA; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; EOSINOPHILS; GATA3 TRANSCRIPTION FACTOR; HISTAMINE ANTAGONISTS; INFLAMMATION; INTERLEUKIN-5; LEUKOCYTE COUNT; LUNG; MALE; OVALBUMIN; RATS; SIGNAL TRANSDUCTION; SULFONIUM COMPOUNDS;

ANIMALIA; RATTUS;

EID: 84878949970     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1485     Document Type: Article

References (35)

1. Rabinovitch N, Silveira L, Gelfand EW and Strand M: The response of children with asthma to ambient particulate is modified by tobacco smoke exposure. Am J Respir Crit Care Med 184: 1350-1357, 2011.
2. Meng W and Busija DW: Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles. Stroke 24: 2041-2044, 1993.
3. Umetsu DT: Revising the immunological theories of asthma and allergy. Lancet 365: 98-100, 2005.
4. Foster PS, Hogan SP, Ramsay AJ, et al: Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity and lung damage in a mouse asthma model. J Exp Med 183: 195-201, 1996. (Pubitemid 26028759)
5. Karras JG, McGraw K, McKay RA, et al: Inhibition of antigen-induced eosinophilia and late phase airway hyperresponsiveness by an IL-5 antisense oligonucleotide in mouse models of asthma. J Immunol 164: 5409-5415, 2000. (Pubitemid 30305223)
6. Tan GH, Su JM, Wang CC, et al: A recombinant DNA plasmid encoding the human interleukin-5 breaks immunological tolerance and inhibits airway inflammation in a murine model of asthma. Int Arch Allergy Immunol 145: 313-323, 2008.
7. Zheng W and Flavell RA: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596, 1997. (Pubitemid 27511769)
8. Yamashita M, Ukai-Tadenuma M, Miyamoto T, et al: Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci. J Biol Chem 279: 26983-26990, 2004. (Pubitemid 38812534)
9. Zhu J, Yamane H, Cote-Sierra J, et al: GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 16: 3-10, 2006. (Pubitemid 43129303)
10. Pai SY, Truitt ML and Ho IC: GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci USA 101: 1993-1998, 2004. (Pubitemid 38229003)
11. Tamaoki J, Takeyama K, Aoshiba K, et al: A TH2 cytokine inhibitor for airway inflammation in mild asthma. J Allergy Clin Immunol 111: 197-198, 2003. (Pubitemid 36143316)
12. Sano Y, Suzuki N, Yamada H, et al: Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma. J Allergy Clin Immunol 111: 958-966, 2003. (Pubitemid 36570854)
13. Hoshino M, Fujita Y, Saji J, et al: Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma. Allergy 60: 1394-1400, 2005. (Pubitemid 41476182)
14. Ding L, Zhou X, Yang L, et al: Liquid chromatography/electrospray ionization mass spectrometry method for the determination of the active metabolite M-1 of suplatast tosilate in human plasma. Biomed Chromatogr 21: 1297-1302, 2007.
15. Satoh T, Sasaki G, Wu MH, et al: Suplatast tosilate inhibits eosinophil production and recruitment into the skin in murine contact sensitivity. Clin Immunol 108: 257-262, 2003. (Pubitemid 37117372)
16. Tanaka A, Minoguchi K, Samson KT, et al: Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma. Clin Exp Allergy 37: 1083-1089, 2007. (Pubitemid 46955512)
17. Agrawal DK, Cheng G, Kim MJ and Kiniwa M: Interaction of suplatast tosilate (IPD) with chloride channels in human blood eosinophils: a potential mechanism underlying its anti-allergic and anti-asthmatic effects. Clin Exp Allergy 38: 305-312, 2008.
18. Tamaoki J, Kondo M, Sakai N, et al: Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group. Lancet 356: 273-278, 2000. (Pubitemid 30459584)
19. Matsumoto K, Hayakawa H, Ide K, et al: Effects of suplatast tosilate on cytokine profile of bronchoalveolar cells in allergic inflammation of the lung. Respirology 7: 201-207, 2002.
20. Zhao GD, Yokoyama A, Kohno N, et al: Effect of suplatast tosilate (IPD-1151T) on a mouse model of asthma: inhibition of eosinophilic inflammation and bronchial hyperresponsiveness. Int Arch Allergy Immunol 121: 116-122, 2000. (Pubitemid 30130783)
21. Moore RG, Granai CO, Gajewski W, et al: Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultra-staging with hematoxylin and eosin staining. Gynecol Oncol 91: 378-382, 2003. (Pubitemid 37346333)
22. Yang C, Yang Z, Zhang M, et al: Hydrogen sulfide protects against chemical hypoxia-induced cytotoxicity and inflammation in HaCaT cells through inhibition of ROS/NF-κB/COX-2 pathway. PLoS ONE 6: e21971, 2011.
23. Temelkovski J, Hogan SP, Shepherd DP, et al: An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 53: 849-856, 1998. (Pubitemid 28459541)
24. Karol MH: Animal models of occupational asthma. Eur Respir J 7: 555-568, 1994.
25. Vanacker NJ, Palmans E, Pauwels RA and Kips JC: Dose-related effect of inhaled fluticasone on allergen-induced airway changes in rats. Eur Respir J 20: 873-879, 2002. (Pubitemid 35175123)
26. Maneechotesuwan K, Yao X, Ito K, et al: Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease. PLoS Med 6: e1000076, 2009.
27. Tamauchi H, Terashima M, Ito M, et al: Evidence of GATA-3-dependent Th2 commitment during the in vivo immune response. Int Immunol 16: 179-187, 2004. (Pubitemid 38054639)
28. Yoshihara S, Ono M, Yamada Y, et al: Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study. Pediatr Allergy Immunol 20: 486-492, 2009.
29. Humbert M, Corrigan CJ, Kimmitt P, et al: Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 156: 704-708, 1997. (Pubitemid 27396404)
30. + T cells in primary culture: relationship to expression of allergic disease. J Allergy Clin Immunol 99: 563-569, 1997.
31. Shi HZ, Xiao CQ, Zhong D, et al: Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med 157: 204-209, 1998. (Pubitemid 28071284)
32. Karlen S, Mordvinov VA and Sanderson CJ: How is expression of the interleukin-5 gene regulated? Immunol Cell Biol 74: 218-223, 1996. (Pubitemid 26173830)
33. Barnes PJ and Adcock IM: Transcription factors and asthma. Eur Respir J 12: 221-234, 1998. (Pubitemid 28325681)
34. Yamashita N, Tashimo H, Ishida H, et al: Involvement of GATA-3-dependent Th2 lymphocyte activation in airway hyperresponsiveness. Am J Physiol Lung Cell Mol Physiol 290: L1045-L1051, 2006. (Pubitemid 43830847)
35. Szabo SJ, Kim ST, Costa GL, et al: A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669, 2000.